Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wong, Letitia ^a   Hutson, Paul R ^a   Bushman, Wade ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; HYDROXYPROLINE; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; TRITIUM; VIMENTIN; ALPHA 2(I) COLLAGEN; COLLAGEN TYPE I, ALPHA 1 CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COL1A1 GENE; COL1A2 GENE; COL3A1 GENE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; FIBROBLAST; FIBROGENESIS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; LOX GENE; MALE; MMP2 GENE; MMP9 GENE; MOUSE; NONHUMAN; PROSTATE DISEASE; PROSTATE FIBROSIS; PROSTATITIS; PROTEIN EXPRESSION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BACTERIAL INFECTION; COMPLICATION; DISEASE MODEL; ESCHERICHIA COLI; FIBROSIS; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; LOWER URINARY TRACT SYMPTOMS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PROSTATE; PROSTATIC DISEASES;

ANIMALS; BACTERIAL INFECTIONS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LOWER URINARY TRACT SYMPTOMS; MALE; MICE; PROSTATE; PROSTATIC DISEASES;

EID: 84903388397     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100770     Document Type: Article

References (66)

1. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, et al. (2008) The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 54: 1379-1384.
2. Roehrborn CG (2006) Definition of at-risk patients: baseline variables. BJU Int 97 Suppl 2: 7-11; discussion 21-12.
3. Bercovich E, Barabino G, Pirozzi-Farina F, Deriu M (1999) A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis. Arch Ital Urol Androl 71: 287-292.
4. Ma J, Gharaee-Kermani M, Kunju L, Hollingsworth JM, Adler J, et al. (2012) Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol 188: 1375-1381.
5. Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, et al. (2013) Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology 81: 1018-1023.
6. Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W (2007) Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67: 14-21. (Pubitemid 46013463)
7. Boehm BJ, Colopy SA, Jerde TJ, Loftus CJ, Bushman W (2012) Acute bacterial inflammation of the mouse prostate. Prostate 72: 307-317.
8. Marker PC, Donjacour AA, Dahiya R, Cunha GR (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253: 165-174. (Pubitemid 36259879)
9. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, et al. (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64: 2270-2305. (Pubitemid 38339483)
10. Cunha GR, Sekkingstad M, Meloy BA (1983) Heterospecific induction of prostatic development in tissue recombinants prepared with mouse, rat, rabbit and human tissues. Differentiation 24: 174-180. (Pubitemid 13010767)
11. Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51: 1202-1216. (Pubitemid 46436310)
12. Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, et al. (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83: 1131-1146. (Pubitemid 37013048)
13. Robert G, Descazeaud A, Nicolaiew N, Terry S, Sirab N, et al. (2009) Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate 69: 1774-1780.
14. Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Bruggemann H, et al. (2013) A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 73: 1007-1015.
15. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155: 1985-1992.
16. Gordon MK, Hahn RA (2010) Collagens. Cell Tissue Res 339: 247-257.
17. Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123: 4195-4200.
18. Kadler KE, Baldock C, Bella J, Boot-Handford RP (2007) Collagens at a glance. J Cell Sci 120: 1955-1958. (Pubitemid 47009991)
19. Rodés J (2007) Textbook of hepatology from basic science to clinical practice. 3rd ed. Malden, Mass.: Blackwell.
20. Thickett DR, Poole AR, Millar AB (2001) The balance between collagen synthesis and degradation in diffuse lung disease. Sarcoidosis Vasc Diffuse Lung Dis 18: 27-33. (Pubitemid 32280534)
21. Armstrong L, Thickett DR, Mansell JP, Ionescu M, Hoyle E, et al. (1999) Changes in collagen turnover in early acute respiratory distress syndrome. Am J Respir Crit Care Med 160: 1910-1915. (Pubitemid 30004695)
22. Garcia-Bolao I, Lopez B, Macias A, Gavira JJ, Azcarate P, et al. (2008) Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy. Eur Heart J 29: 898-906. (Pubitemid 351499498)
23. Selman M, Montano M, Ramos C, Chapela R (1986) Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 41: 355-359. (Pubitemid 16114960)
24. Pardo A, Selman M (2002) Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biol 34: 1534-1538.
25. Selman M, King TE, Pardo A, American Thoracic S, European Respiratory S, et al. (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151. (Pubitemid 32096342)
26. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
27. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, et al. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121. (Pubitemid 41002048)
28. Rieder F, Fiocchi C (2009) Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 6: 228-235.
29. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
30. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, et al. (2004) Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110: 1263-1268. (Pubitemid 39202343)
31. McLenachan JM, Dargie HJ (1990) Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 3: 735-740. (Pubitemid 20345997)
32. Broughton G, 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117: 12S-34S. (Pubitemid 44317769)
33. Borthwick LA, Wynn TA, Fisher AJ (2013) Cytokine mediated tissue fibrosis. Biochim Biophys Acta 1832: 1049-1060.
34. Atamas SP (2002) Complex cytokine regulation of tissue fibrosis. Life Sci 72: 631-643.
35. Ueha S, Shand FH, Matsushima K (2012) Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Front Immunol 3: 71.
36. Wight TN, Potter-Perigo S (2011) The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 301: G950-955.
37. Rydell-Tormanen K, Andreasson K, Hesselstrand R, Risteli J, Heinegard D, et al. (2012) Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. Lab Invest 92: 917-925.
38. Lv XX, Wang XX, Li K, Wang ZY, Li Z, et al. (2013) Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents. PLoS One 8: e68631.
39. Besnard AG, Struyf S, Guabiraba R, Fauconnier L, Rouxel N, et al. (2013) CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model. J Leukoc Biol 94: 1317-1323.
40. Kang HR, Cho SJ, Lee CG, Homer RJ, Elias JA (2007) Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem 282: 7723-7732. (Pubitemid 47093708)
41. Gharaee-Kermani M, McGarry B, Lukacs N, Huffnagle G, Egan RW, et al. (1998) The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol 64: 657-666. (Pubitemid 28511987)
42. Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, et al. (2011) TGFbeta signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment. Am J Physiol Lung Cell Mol Physiol 300: L887-897.
43. Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, et al. (2008) Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 38: 566-571. (Pubitemid 351758675)
44. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552.
45. Vater CA, Harris ED, Jr., Siegel RC (1979) Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J 181: 639-645. (Pubitemid 10241711)
46. Lagente V, Manoury B, Nenan S, Le Quement C, Martin-Chouly C, et al. (2005) Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 38: 1521-1530. (Pubitemid 41440223)
47. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526-537.
48. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113: 243-252. (Pubitemid 38544209)
49. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446. (Pubitemid 39071616)
50. Peng X, Mathai SK, Murray LA, Russell T, Reilkoff R, et al. (2011) Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor beta1-induced lung fibrosis. Fibrogenesis Tissue Repair 4: 12.
51. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, et al. (2007) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353: 104-108. (Pubitemid 44958347)
52. Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, et al. (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 2129-2140.
53. Galligan CL, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, et al. (2010) Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 49: 640-651.
54. Galligan CL, Fish EN (2012) Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis. Arthritis Rheum 64: 3583-3593.
55. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171: 380-389. (Pubitemid 36745311)
56. Wang CH, Huang CD, Lin HC, Lee KY, Lin SM, et al. (2008) Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 178: 583-591.
57. Sakai N, Furuichi K, Shinozaki Y, Yamauchi H, Toyama T, et al. (2010) Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum Pathol 41: 672-678.
58. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, et al. (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103: 14098-14103. (Pubitemid 44452986)
59. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
60. Pilling D, Fan T, Huang D, Kaul B, Gomer RH (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4: e7475.
61. Gharaee-Kermani M, Kasina S, Moore BB, Thomas D, Mehra R, et al. (2012) CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. PLoS One 7: e49278.
62. Morrison C, Thornhill J, Gaffney E (2000) The connective tissue framework in the normal prostate, BPH and prostate cancer: analysis by scanning electron microscopy after cellular digestion. Urol Res 28: 304-307.
63. Barron DA, Strand DW, Ressler SJ, Dang TD, Hayward SW, et al. (2010) TGFbeta1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One 5: e13751.
64. Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455. (Pubitemid 9238595)
65. Hutson PR, Crawford ME, Sorkness RL (2003) Liquid chromatographic determination of hydroxyproline in tissue samples. J Chromatogr B Analyt Technol Biomed Life Sci 791: 427-430. (Pubitemid 36638776)
66. McAnulty RJ (2005) Methods for measuring hydroxyproline and estimating in vivo rates of collagen synthesis and degradation. Methods Mol Med 117: 189-207.